11425552

Source:http://linkedlifedata.com/resource/pubmed/id/11425552

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists.
Subject	Predicate	Object	Context
pubmed-article:11425552	rdf:type	pubmed:Citation	lld:pubmed
pubmed-article:11425552	lifeskim:mentions	umls-concept:C0030281	lld:lifeskim
pubmed-article:11425552	lifeskim:mentions	umls-concept:C1256369	lld:lifeskim
pubmed-article:11425552	lifeskim:mentions	umls-concept:C0243077	lld:lifeskim
pubmed-article:11425552	pubmed:issue	13	lld:pubmed
pubmed-article:11425552	pubmed:dateCreated	2001-6-26	lld:pubmed
pubmed-article:11425552	pubmed:abstractText	3,5-Disubstituted-phenylcyanoguanidines have been identified as activators of SUR1/Kir6.2 potassium channels and as potent inhibitors of insulin release from pancreatic beta cells in vitro.	lld:pubmed
pubmed-article:11425552	pubmed:language	eng	lld:pubmed
pubmed-article:11425552	pubmed:journal	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:11425552	pubmed:citationSubset	IM	lld:pubmed
pubmed-article:11425552	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:11425552	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:11425552	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:11425552	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:11425552	pubmed:status	MEDLINE	lld:pubmed
pubmed-article:11425552	pubmed:month	Jul	lld:pubmed
pubmed-article:11425552	pubmed:issn	0960-894X	lld:pubmed
pubmed-article:11425552	pubmed:author	pubmed-author:WahlPP	lld:pubmed
pubmed-article:11425552	pubmed:author	pubmed-author:HansenJ BJB	lld:pubmed
pubmed-article:11425552	pubmed:author	pubmed-author:WorsaaeAA	lld:pubmed
pubmed-article:11425552	pubmed:author	pubmed-author:MogensenJ PJP	lld:pubmed
pubmed-article:11425552	pubmed:author	pubmed-author:ArkhammarP...	lld:pubmed
pubmed-article:11425552	pubmed:author	pubmed-author:TagmoseT MTM	lld:pubmed
pubmed-article:11425552	pubmed:author	pubmed-author:AgerholmP CPC	lld:pubmed
pubmed-article:11425552	pubmed:issnType	Print	lld:pubmed
pubmed-article:11425552	pubmed:day	9	lld:pubmed
pubmed-article:11425552	pubmed:volume	11	lld:pubmed
pubmed-article:11425552	pubmed:owner	NLM	lld:pubmed
pubmed-article:11425552	pubmed:authorsComplete	Y	lld:pubmed
pubmed-article:11425552	pubmed:pagination	1749-52	lld:pubmed
pubmed-article:11425552	pubmed:dateRevised	2011-11-17	lld:pubmed
pubmed-article:11425552	pubmed:meshHeading	pubmed-meshheading:11425552...	lld:pubmed
pubmed-article:11425552	pubmed:meshHeading	pubmed-meshheading:11425552...	lld:pubmed
pubmed-article:11425552	pubmed:meshHeading	pubmed-meshheading:11425552...	lld:pubmed
pubmed-article:11425552	pubmed:meshHeading	pubmed-meshheading:11425552...	lld:pubmed
pubmed-article:11425552	pubmed:meshHeading	pubmed-meshheading:11425552...	lld:pubmed
pubmed-article:11425552	pubmed:meshHeading	pubmed-meshheading:11425552...	lld:pubmed
pubmed-article:11425552	pubmed:meshHeading	pubmed-meshheading:11425552...	lld:pubmed
pubmed-article:11425552	pubmed:year	2001	lld:pubmed
pubmed-article:11425552	pubmed:articleTitle	Phenylcyanoguanidines as inhibitors of glucose-induced insulin secretion from beta cells.	lld:pubmed
pubmed-article:11425552	pubmed:affiliation	Discovery and Development, Novo Nordisk A/S, Novo Nordisk Park, DK-2760, Måløv, Denmark.	lld:pubmed
pubmed-article:11425552	pubmed:publicationType	Journal Article	lld:pubmed
pubmed-article:11425552	pubmed:publicationType	In Vitro	lld:pubmed
http://linkedlifedata.com/r...	http://linkedlifedata.com/r...	pubmed-article:11425552	lld:chembl